Acetaminophen Oral Solution

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, backache, minor pain of arthritis, the common cold, toothache, and premenstrual and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should determine the appropriate dosage based on the patient's weight whenever possible; if weight is not available, age may be used as a guide. The following dosage chart provides specific recommendations:

• For patients under 2 years of age, consultation with a physician is required.

• For patients aged 2 to 3 years, the recommended dosage is 1 teaspoonful (5 ml).

• For patients aged 4 to 5 years, the recommended dosage is 1 1/2 teaspoonfuls (7.5 ml).

• For patients aged 6 to 8 years, the recommended dosage is 2 teaspoonfuls (10 ml).

• For patients aged 9 to 10 years, the recommended dosage is 2 1/2 teaspoonfuls (12.5 ml).

• For patients aged 11 years, the recommended dosage is 3 teaspoonfuls (15 ml).

• For patients aged 12 years and older, the recommended dosage is 4 teaspoonfuls (20 ml).

Dosage may be repeated every 4 hours as needed, or as directed by a physician. It is important to note that no more than 5 doses should be administered within a 24-hour period.

Contraindications

Use of this product is contraindicated in patients who are concurrently taking any other medication that contains acetaminophen, whether prescription or nonprescription. This is due to the potential risk of acetaminophen overdose, which can lead to serious liver damage. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Warnings and Precautions

This product contains acetaminophen, which carries significant risks for liver damage. Healthcare professionals should be aware that severe liver injury may occur under the following circumstances:

• Adults should not exceed 6 doses within a 24-hour period, as this represents the maximum daily dosage.

• Children should not take more than 5 doses in a 24-hour period, which is also the maximum daily amount for pediatric patients.

• Concurrent use with other medications containing acetaminophen increases the risk of liver damage.

• Adults consuming 3 or more alcoholic beverages daily while using this product are at heightened risk for liver injury.

In addition to the liver warning, there is an allergy alert associated with acetaminophen. Severe skin reactions may occur, presenting symptoms such as skin reddening, blisters, and rash. Should any skin reaction manifest, it is imperative to discontinue use immediately and seek medical assistance.

Healthcare professionals should advise patients to stop using the product and consult a physician if any of the following occur:

• Pain worsens or persists beyond 10 days in adults or 5 days in children under 12 years.

• Fever intensifies or lasts more than 3 days.

• New symptoms develop.

• Redness or swelling is observed.

These symptoms may indicate a serious underlying condition that requires further evaluation.

In the event of an overdose, immediate medical attention is essential. Patients or caregivers should contact a Poison Control Center or seek emergency medical help without delay, even if no signs or symptoms are apparent, as prompt intervention is critical for both adults and children.

Side Effects

Severe liver damage may occur in patients who exceed the recommended dosage of acetaminophen. Specifically, adults should not take more than 6 doses within a 24-hour period, while children should not exceed 5 doses in the same timeframe. The risk of liver damage is further increased if acetaminophen is taken in conjunction with other medications containing acetaminophen or if an adult consumes 3 or more alcoholic drinks daily while using the product.

Patients should be aware of the potential for severe skin reactions associated with acetaminophen use. Symptoms may include skin reddening, blisters, and rash. In the event of a skin reaction, it is imperative to discontinue use and seek medical assistance immediately.

Participants in clinical trials and postmarketing experiences have indicated that patients should stop using the product and consult a healthcare professional if pain worsens or persists beyond 10 days in adults or 5 days in children under 12 years. Additionally, if fever worsens or lasts more than 3 days, or if new symptoms arise, medical advice should be sought. The presence of redness or swelling may also indicate a serious condition requiring attention.

It is advised that patients consult a doctor prior to use if they have liver disease or if they are currently taking the blood-thinning medication warfarin.

Drug Interactions

Acetaminophen has been observed to enhance the anticoagulant effects of warfarin, which may result in an elevated risk of bleeding complications. It is recommended that the International Normalized Ratio (INR) be monitored closely in patients receiving both acetaminophen and warfarin to ensure safe therapeutic levels and to mitigate the risk of adverse effects.

No additional drug interactions or interactions with laboratory tests have been identified.

Packaging & NDC

Below are the non-prescription pack sizes of Acetaminophen Oral Solution (acetaminophen 160mg/5ml). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients with liver disease should consult a physician before use. The recommended dosage may be repeated every 4 hours, as directed by a healthcare professional, but should not exceed 5 doses within a 24-hour period.

The following dosage chart is provided for children:

• Under 2 years: Consult a physician

• 2 to 3 years: 1 tsp (5 mL)

• 4 to 5 years: 1 1/2 tsp (7.5 mL)

• 6 to 8 years: 2 tsp (10 mL)

• 9 to 10 years: 2 1/2 tsp (12.5 mL)

• 11 years: 3 tsp (15 mL)

• 12 years and older: 4 tsp (20 mL)

Healthcare professionals should advise caregivers to discontinue use and consult a doctor if a child's pain worsens or persists for more than 5 days, or if a fever worsens or lasts more than 3 days.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully known. Therefore, it is essential for women of childbearing potential to seek medical advice prior to use to ensure appropriate management and consideration of any potential risks.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, which contains acetaminophen. Severe liver damage may occur if the following conditions are met:

• Adults should not exceed 6 doses in a 24-hour period, which is the maximum daily amount.

• Children should not exceed 5 doses in a 24-hour period, which is the maximum daily amount.

• Caution is advised when this product is taken concurrently with other medications containing acetaminophen, as this may increase the risk of liver damage.

• Adults who consume 3 or more alcoholic drinks daily while using this product are at an elevated risk for severe liver damage.

It is recommended that healthcare providers assess liver function and consider dosage adjustments or alternative therapies for patients with compromised liver function to mitigate the risk of hepatotoxicity. Regular monitoring of liver enzymes may be warranted in these patients to ensure safety and efficacy.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be tailored to the individual patient and may involve supportive care, symptomatic treatment, and, if applicable, the use of specific antidotes. It is crucial to consult local poison control guidelines and the product's prescribing information for detailed management protocols.

In all instances of suspected overdose, prompt reporting and documentation of the event are recommended to ensure patient safety and facilitate further investigation if necessary.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified. Additionally, there are no detailed findings related to nonclinical toxicology or animal pharmacology and toxicology available.

Postmarketing Experience

Postmarketing experience has identified rare cases of severe skin reactions associated with acetaminophen use. Reported symptoms include skin reddening, blisters, and rash. These events were documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose, emphasizing that prompt medical attention is crucial for both adults and children, even if no signs or symptoms are apparent.

Patients should be informed not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or nonprescription. If patients are uncertain about the presence of acetaminophen in their medications, they should be encouraged to consult with a doctor or pharmacist for clarification.

Providers should instruct patients to discontinue use and consult a doctor if any of the following occur: pain worsens or persists for more than 10 days in adults or more than 5 days in children under 12 years; fever worsens or lasts more than 3 days; new symptoms arise; or if there is any redness or swelling. These symptoms may indicate a serious underlying condition that requires medical evaluation.

It is important to remind patients to adhere strictly to the recommended dosage and not to exceed it while using this product. Additionally, healthcare providers should advise patients to consult a doctor before use if their child has liver disease or if they are currently taking the anticoagulant medication warfarin, as these conditions may necessitate special consideration.

Storage and Handling

The product is supplied in a container that is tamper evident, ensuring safety and integrity. Healthcare professionals should verify that the foil seal over the bottle opening is intact; the product should not be used if the seal is torn, broken, or missing.

Storage conditions require the product to be maintained at room temperature, specifically between 15-30°C (59-86°F). It is crucial to avoid freezing the product and to protect it from light exposure to preserve its efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Acetaminophen Oral Solution, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)